XRAY Price Prediction Next Week
Prediction and Recommendation for XRAY Stock
Based on the analysis of news sentiment and technical indicators, here is the prediction and recommendation for Dentsply Sirona (XRAY) stock:
News Sentiment Analysis:
- Negative Sentiment: Recent downgrades by Needham to Hold, weak growth outlook, and disappointing earnings.
- Market Challenges: Declining consumer sentiment, high interest rates, and staffing shortages in the dental sector.
Technical Indicators Analysis:
- RSI (14): 34.08 (Oversold range, potential for rebound).
- MACD: -0.76 (Bearish momentum).
- SMA (50): $18.07 (Stock trading below, bearish signal).
- SMA (200): $22.08 (Stock trading below, bearish signal).
- Fibonacci Levels:
- Support 1: $14.97
- Resistance 1: $16.22
Price Prediction:
- Target Price: $14.97 (Lower Fibonacci support level).
- Resistance Level: $16.22 (Upper Fibonacci resistance level).
Recommendation:
- Sell: Based on bearish momentum and negative news sentiment, the stock is expected to trend downward in the short term.
- Stop-Loss: Set at $16.22 (Fibonacci resistance level).
Conclusion:
The stock is likely to test the lower Fibonacci support level of $14.97 in the next trading week. Investors should consider selling at current levels with a stop-loss at $16.22.
XRAY Similar Chart Price Prediction
The price of XRAY is predicted to go up -1.94%, based on the high correlation periods with GFF. The similarity of these two price pattern on the periods is 98.98%.
XRAY
GFF
Down: -1.94%Similarity: 98.98%
XRAY Revenue Forecast
XRAY EPS Forecast
XRAY FAQs
What is XRAY revenue forecast for next quarter？
What is XRAY eps forecast for next quarter？
XRAY VS S&P500
Expertise and leadership in digital dentistry positions the firm well to enjoy tailwinds as more doctors move away from dental labs and adopt chairside solutions.
The firm can utilize its scale and experience to help build up its orthodontics business, a market that we expect to increase by double-digits over the next five years.
Management has restructured to better integrate Dentsply and Sirona and create a more harmonious and simplified operation which could lower operating expenses over the long term.
XRAY Analyst's Forecast
Steven Valiquette
Mizuho
Hold
2025-03-13
Price Target
$21 → $18
Upside
+20%
Mizuho lowered the firm's price target on Dentsply Sirona to $18 from $21 and keeps a Neutral rating on the shares following the investor conference. A key "make or break" dynamic for Dentsply in 2025 is the rate of uptake of its new Primescan 2 cloud-based intraoral scanner, and management has provided limited data on uptake so far, the analyst tells investors in a research note. The firm reduced estimates to reflect reflect slower growth.
David Saxon
Needham
Strong Buy → Hold
2025-03-13
Price Target
n/a
Downside
0%
Vik Chopra
Wells Fargo
Hold
2025-02-14
Price Target
$20
Upside
+9.17%
